Kerry Welsh

Kerry Welsh is a pharmacovigilance physician with extensive experience in medical review and analysis, particularly concerning vaccine and biologic products. From 2018 to 2022, Kerry served as a Medical Officer at the FDA, where they conducted safety assessments and developed pharmacovigilance strategies. Prior to that, Kerry held various positions, including Branch Chief at the FDA and Clinical Pathology Resident at The University of Texas Health Science Center. Currently, Kerry is a Medical Director and Senior Patient Safety Physician at AstraZeneca and is pursuing a Ph.D. in Biomedical Sciences. Kerry also holds a Master's in Public Health from Emory University.